2026
Filter by topic
- All
- Corporate
- Advanced Wound Care
- Infusion Care
- Ostomy Care
- Our People
- Communities
- Financial Performance
09-Jun-26
Convatec and Lilly Foundation commit $5m to Partners In Health to improve care for non-communicable disease and chronic conditions
Corporate Communities04-Jun-26
Convatec announces leadership appointments to strengthen Science, Innovation, Quality and Regulatory Affairs
Corporate Our People21-May-26
AGM trading update for the four months ended 30 April 2026
Corporate Financial Performance05-May-26
Convatec’s Advanced Wound Care innovation leads the industry at European Wound Management Association (EWMA) 2026
Corporate Advanced Wound Care21-Apr-26
Convatec appoints Peter Jarvis as Chief Operations Officer
Corporate Our People09-Apr-26
Convatec announces ‘Accelerate’ strategy to drive the next chapter of sustainable and profitable growth
Corporate20-Mar-26
Championing better support for people living with chronic conditions
Corporate Ostomy Care24-Feb-26
Annual results for the year ended 31 December 2025
Corporate03-Feb-26
Update relating to Unomedical following United States Food and Drug Administration (FDA) Remote Regulatory Assessment
Corporate Infusion Care